Full Factorial Experimental Design for Development and Validation of a RP-HPLC Method for Estimation of Letrozole in Nanoformulations

Title:Full Factorial Experimental Design for Development and Validation of a RP-HPLC Method for Estimation of Letrozole in Nanoformulations

Volume: 14 Issue: 3

Author(s): Aswathi R. Hegde, Renuka S. Managuli, Anup Naha, Kunnatur B. Koteshwara, Meka Sreenivasa Reddy and Srinivas Mutalik*

Affiliation:

• Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, Karnataka State,India

Keywords: Optimization, validation, high performance liquid chromatography, factorial design, letrozole, nanoformulations.

Abstract: Background: Letrozole (LTZ) is a potent aromatase inhibitor which blocks estrogen synthesis in post-menopausal women. Suitable analytical methods are required to quantify letrozole in bulk and its nanoformulations. Hence a sensitive and robust reverse-phase high performance liquid chromatographic method (RP-HPLC) was developed for the estimation of LTZ.

Methods: The method was developed using Kinetex C18 column (250 mm×4.6 mm; 5µ) and mobile phase comprising acetonitrile (ACN): acetate buffer (pH 4.5) mixture (50:50% v/v) was used to affect the chromatographic separation at 0.8 mL/min flow rate. The responses were measured at 240 nm. Force degradation studies were done by exposing LTZ to acid- and alkali-induced hydrolysis, oxidation (H2O2), thermal and photolysis. Two-level factorial design was used to validate the method as per ICH Q2 (R1) using Design-Expert® software. The effects of independent variables on flow rate, pH, acetonitrile content and column temperature were recorded as responses.

Results: Method was linear over the concentration range of 5-2500 ng/mL with a correlation coefficient (R2) of 1.000. Force degradation studies revealed that LTZ was stable to all stress agents except the basic conditions. The inter-day precision results were reproducible with relative standard deviation (% RSD) of 0.078. The peak area RSD and mean recovery of LTZ was found to be <1.0% and 99-102% in drug solution and <1.0% and 98-106% in nanoformulations respectively. Deliberate changes in independent chromatographic parameters analyzed using analysis of variance (ANOVA) indicated that the model was significant (p<0.0001).

Conclusion: The developed analytical method was successfully utilized to quantify LTZ in bulk and its nanoformulations.

Cite this article as:

Hegde R. Aswathi , Managuli S. Renuka , Naha Anup , Koteshwara B. Kunnatur , Reddy Sreenivasa Meka and Mutalik Srinivas *, Full Factorial Experimental Design for Development and Validation of a RP-HPLC Method for Estimation of Letrozole in Nanoformulations, Current Pharmaceutical Analysis 2018; 14 (3) . https://dx.doi.org/10.2174/1573412913666171006152604